Found: 64
Select item for more details and to access through your institution.
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 1, p. 94, doi. 10.1002/hup.2374
- By:
- Publication type:
- Article
Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.
- Published in:
- Frontiers in Psychiatry, 2021, v. 12, p. 1, doi. 10.3389/fpsyt.2021.687546
- By:
- Publication type:
- Article
Hallucinations and Hallucinogens: Psychopathology or Wisdom?
- Published in:
- Culture, Medicine & Psychiatry, 2023, v. 47, n. 2, p. 576, doi. 10.1007/s11013-022-09814-0
- By:
- Publication type:
- Article
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 11, p. 1618, doi. 10.3390/biom12111618
- By:
- Publication type:
- Article
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.856846
- By:
- Publication type:
- Article
Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.881617
- By:
- Publication type:
- Article
Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples.
- Published in:
- Molecules, 2020, v. 25, n. 9, p. 2072, doi. 10.3390/molecules25092072
- By:
- Publication type:
- Article
Neuroinflammation and schizophrenia - is there a link?
- Published in:
- Frontiers in Psychiatry, 2024, p. 1, doi. 10.3389/fpsyt.2024.1356975
- By:
- Publication type:
- Article
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol.
- Published in:
- Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00359
- By:
- Publication type:
- Article
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00343
- By:
- Publication type:
- Article
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
- Published in:
- Psychopharmacology, 2022, v. 239, n. 9, p. 2713, doi. 10.1007/s00213-022-06196-4
- By:
- Publication type:
- Article
The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020).
- Published in:
- Psychopharmacology, 2022, v. 239, n. 6, p. 1977, doi. 10.1007/s00213-021-05964-y
- By:
- Publication type:
- Article
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial.
- Published in:
- Psychopharmacology, 2021, v. 238, n. 2, p. 453, doi. 10.1007/s00213-020-05692-9
- By:
- Publication type:
- Article
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 3, p. 312, doi. 10.1177/0269881112474524
- By:
- Publication type:
- Article
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 2, p. 274, doi. 10.1177/0269881109106925
- By:
- Publication type:
- Article
Cannabidiol monotherapy for treatment-resistant schizophrenia.
- Published in:
- Journal of Psychopharmacology, 2006, v. 20, n. 5, p. 683, doi. 10.1177/0269881106060967
- By:
- Publication type:
- Article
Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomy.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Guidelines for Establishing Safety in Ayahuasca and Ibogaine Administration in Clinical Settings.
- Published in:
- Psychoactives, 2023, v. 2, n. 4, p. 373, doi. 10.3390/psychoactives2040024
- By:
- Publication type:
- Article
Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology.
- Published in:
- 2023
- By:
- Publication type:
- Obituary
The first department of medical psychology in the world and its impact on medical education.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2016, v. 38, n. 1, p. 65, doi. 10.1590/1516-4446-2015-1701
- By:
- Publication type:
- Article
Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2013, v. 35, n. 4, p. 380, doi. 10.1590/1516-4446-2012-0886
- By:
- Publication type:
- Article
Why we should use long-acting injectable antipsychotics more frequently.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
The quest for better diagnosis: DSM-5 or RDoC?
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Nitric oxide plasma/serum levels in patients with schizophrenia: A systematic review and meta-analysis.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2012, v. 34, n. S2, p. S149, doi. 10.1016/j.rbp.2012.07.001
- By:
- Publication type:
- Article
Neuroimaging in specific phobia disorder: a systematic review of the literature.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2012, v. 34, n. 1, p. 101, doi. 10.1016/S1516-4446(12)70017-X
- By:
- Publication type:
- Article
Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2011, v. 33, n. 3, p. 223, doi. 10.1590/S1516-44462011000300003
- By:
- Publication type:
- Article
New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Novas perspectivas e diretrizes na terapêutica da esquizofrenia: avanços relacionados com os sistemas não-dopaminérgicos.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2010, v. 32, n. 4, p. 336, doi. 10.1590/S1516-44462010000400003
- By:
- Publication type:
- Article
Cannabis sativa: a planta que pode produzir efeitos indesejáveis e também tratá-los.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2010, v. 32, p. S1
- By:
- Publication type:
- Article
Uso terapêutico dos canabinoides em psiquiatria.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2010, v. 32, p. S56
- By:
- Publication type:
- Article
National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2010, v. 32, n. 1, p. 83, doi. 10.1590/S1516-44462010000100016
- By:
- Publication type:
- Article
Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD).
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2010, v. 32, n. 1, p. 56, doi. 10.1590/S1516-44462010000100011
- By:
- Publication type:
- Article
Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study: Le cannabidiol comme traitement d'appoint de la dépression bipolaire aiguë : une étude pilote.
- Published in:
- Canadian Journal of Psychiatry, 2024, v. 69, n. 4, p. 242, doi. 10.1177/07067437231209650
- By:
- Publication type:
- Article
Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside: A Randomized, Double-blind, Placebo-Controlled Trial.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside.
- Published in:
- JAMA Psychiatry, 2013, v. 70, n. 7, p. 668, doi. 10.1001/jamapsychiatry.2013.1292
- By:
- Publication type:
- Article
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00482
- By:
- Publication type:
- Article
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00399
- By:
- Publication type:
- Article
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.
- Published in:
- Frontiers in Pharmacology, 2017, v. 8, p. 1, doi. 10.3389/fphar.2017.00259
- By:
- Publication type:
- Article
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy.
- Published in:
- Frontiers in Pharmacology, 2017, v. 8, p. 1, doi. 10.3389/fphar.2017.00131
- By:
- Publication type:
- Article
Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41199-x
- By:
- Publication type:
- Article
Cross-cultural adaptation of the Internet Gaming Disorder Scale - Short Form (IGDS9-SF) to the Brazilian context.
- Published in:
- Trends in Psychiatry & Psychotherapy, 2020, v. 42, n. 3, p. 262, doi. 10.1590/2237-6089-2019-0032
- By:
- Publication type:
- Article
Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT<sub>2A</sub> and 5‐HT<sub>1A</sub> receptors.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 11, p. 1671, doi. 10.1111/bph.16315
- By:
- Publication type:
- Article
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118143
- By:
- Publication type:
- Article
Increased Amygdalar and Hippocampal Volumes in Young Adults with Social Anxiety.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088523
- By:
- Publication type:
- Article
Lipoma adhered to the corpus callosum in a schizophrenic patient with severe positive symptoms that responded to clozapine.
- Published in:
- Acta Neuropsychiatrica, 2002, v. 14, n. 1, p. 36, doi. 10.1034/j.1601-5215.2002.140105.x
- By:
- Publication type:
- Article
Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10393-8
- By:
- Publication type:
- Article
Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.00901
- By:
- Publication type:
- Article
Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.
- Published in:
- International Journal of Neuropsychopharmacology, 2017, v. 20, n. 9, p. 698, doi. 10.1093/ijnp/pyx036
- By:
- Publication type:
- Article
Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies.
- Published in:
- European Archives of Psychiatry & Clinical Neuroscience, 2023, v. 273, n. 7, p. 1527, doi. 10.1007/s00406-023-01590-1
- By:
- Publication type:
- Article